跳至主要内容
临床试验/CTIS2024-511568-96-00
CTIS2024-511568-96-00进行中(未招募)1 期

Safety and pharmacokinetics of antipsychotics in children 2: Studying TDM in an RCT - NL75882.078.20

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)0 个研究点目标入组 280 人开始时间: 2024年6月20日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
280

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 64(—)
性别
All

入选标准

  • ? Age 6 to 18 years ? Documented clinical diagnosis of autism spectrum disorder according to DSM IV or DSM V and comorbid behavioural problems ? To start treatment with risperidone or aripiprazole

排除标准

  • ? Diabetes type I or II ? Congenital or acquired syndrome associated with changes in appetite, body weight or lipid profile (e.g. Prader Willi) ? Known history of Long QT syndrome (LQTS), cardiovascular disorders (myocardial infarction or ischaemic heart disease, heart failure, or conduction abnormalities), seizure disorder or oesophageal dysmotility ? Pregnancy ? Hypersensitivity to the active substance or to any of the excipients

研究者

相似试验